Literature DB >> 32633333

Reply Letter - COVID-19 (Novel Coronavirus 2019) - Recent trends.

S Kannan1, P Shaik Syed Ali Pakeer, A Sheeza Ali, K Hemalatha.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32633333     DOI： 10.26355/eurrev_202006_21629

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN： 1128-3602            Impact factor:   3.507


× No keyword cloud information.
  3 in total

1.  Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019.

Authors:  Dominic Kaddu-Mulindwa; Torben Rixecker; Vadim Lesan; Moritz Bewarder; Carlos Metz; André Becker; Sebastian Mang; Evi Regitz; Lorenz Thurner; Frank Neumann; Igor Kos; Konstantinos Christofyllakis; Guy Danziger; Stephan Stilgenbauer; Robert Bals; Philipp M Lepper
Journal:  Intensive Care Med Exp       Date:  2021-09-03

Review 2.  A comprehensive update on the structure and synthesis of potential drug targets for combating the coronavirus pandemic caused by SARS-CoV-2.

Authors:  Prerna Malik; Sonika Jain; Pankaj Jain; Jyoti Kumawat; Jaya Dwivedi; Dharma Kishore
Journal:  Arch Pharm (Weinheim)       Date:  2022-01-17       Impact factor: 4.613

3.  Discovery of novel pyrazole derivatives as a potent anti-inflammatory agent in RAW264.7 cells via inhibition of NF-ĸB for possible benefit against SARS-CoV-2.

Authors:  Anup Masih; Amol K Agnihotri; Jitendra K Srivastava; Nidhi Pandey; Hans R Bhat; Udaya P Singh
Journal:  J Biochem Mol Toxicol       Date:  2020-10-23       Impact factor: 3.568
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.